Skip to main content

Table 1 Description of the obtained RT-PCR results by protocol

From: SARS-CoV2 RT-PCR assays: In vitro comparison of 4 WHO approved protocols on clinical specimens and its implications for real laboratory practice through variant emergence

 

Protocols and targets

BERLIN

BERLIN E

BERLIN RdRp

HKU

HKU N

HKU Orf1b

DAAN Gene®

DAAN Gene® N

DAAN Gene® Orf1ab

IPP

IPP IP2

IPP IP4

“Positive”: target amplification by both targets  per protocol

POSITIVE n(%)

n = 116 (44.6%)

116 (100%)

116 (100%)

n = 112 (43.1%)

112 (100%)

112 (100%)

n = 143

(55%)

143 (100%)

143 (100%)

n = 89

(35%)

89 (100%)

89 (100%)

 

Ct value

Median [min, max]

 

29 [16.39]

31 [18.39]

 

28[12.39]

27.5[16.39]

 

25[13.39]

28[16.39]

 

27[15.38]

27[15.39]

 

Ct value mean +/− SD

 

28.9 +/− 5.2

30.5 +/− 4.8

 

27.4 +/− 5.9

27.5 +/− 5.9

 

26.2 +/− 6.6

28.5 +/− 6.1

 

27.4 +/− 5.8

27.4 +/− 6.4

 

MEAN PAIRED DIFFERENCE +/− SD

 

1.5 +/− 2

  

0.2 +/− 1.9

  

2.3 +/− 2

  

0.04 +/− 1.6

 
 

PAIRED SAMPLE t-TEST

 

p < 0.0001

  

p = 0.3

  

p < 0.0001

  

p = 0.8

 

« Partial positive»

Target amplification by one target per protocol

POSITIVE n (%)

n = 17 (6.5%)

15 (88.2%)

2 (11.7%)

n = 17 (6.5%)

15 (88.2%)

2 (11.7%)

n = 39

(15%)

37 (94.9%)

2 (5.1%)

n = 44

(16.9%)

38 (86.4%)

6 (13.6%)

 

Ct value

Median [min, max]

 

37[24. 39]

33.5[33. 34]

 

36[31.38]

38[37.39]

 

38[35.39]

39[39.39]

 

24.5[15.38]

33.5[32.38]

 

Ct value mean +/− SD

 

36 +/− 3.8

33.5 +/− 0.7

 

36 +/− 1.9

38 +/− 1.4

 

37.7 +/− 1.2

39 +/− 0

 

25.2 +/− 6.4

34.3 +/− 2.2

 

NEGATIVE n (%)

 

2 (11.7%)

15 (88.2%)

 

2 (11.7%)

15 (88.2%)

 

2 (5.1%)

37 (94.9%)

 

6 (13.6%)

38 (86.4%)

« NEGATIVE»

No target amplification by both targets per protocol, n(%)

 

n = 127 (48.8%)

127 (100%)

127 (100%)

n = 131. (50.4%)

131 (100%)

131 (100%)

n = 78 (30%)

78 (100%)

78 (100%)

n = 125 (48.10%)

127 (100%)

127 (100%)

Total

 

260 (100%)

260

(100%)

260

(100%)

260 (100%)

260

(100%)

260 (100%)

260 (100%)

260 (100%)

260 (100%)

260 (100%)

260

(100%)

260

(100%)

  1. Charité, Berlin protocol (BERLIN): Berlin E and Berlin RdRp, University of Hong Kong protocol (HKU): HKU N and HKU Orf 1b, DAAN Gene® protocol (DAAN Gene®): DAAN Gene® N and DAAN Gene® Orf1ab, The Institut Pasteur, Paris (IPP) protocol: IPP IP2 and IPP IP4. Ct value: cycle threshold value, min: minimum, max: maximum, SD: standard deviation